XML 25 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Feb. 02, 2019
Feb. 03, 2018
Jan. 28, 2017
Operating activities:      
Net income $ 170,263 $ 221,324 $ 169,220
Depreciation and amortization of property and other deferred costs 225,849 233,683 245,923
Adjustments to reconcile net income to net cash provided by operating activities:      
Deferred income taxes 334 (102,065) (35,703)
Gain on disposal of assets, excluding insurance gain (48) (1,000) 905
Proceeds from Insurance Settlement, Operating Activities 0 0 3,173
Insured Event, Gain (Loss) 0 (5,861) (1,635)
Write off of Deferred Debt Issuance Cost 0 797 0
Asset impairment and store closing charges 0 0 6,500
Changes in operating assets and liabilities:      
(Increase) decrease in accounts receivable (11,416) 8,871 (1,743)
Increase in merchandise inventories (64,856) (57,158) (33,436)
(Increase) decrease in other current assets (17,416) (1,902) 9,224
(Increase) decrease in other assets (10,419) 2,196 1,047
Increase (decrease) in trade accounts payable and accrued expenses and other liabilities 104,060 (20,395) 156,750
Decrease in income taxes payable (29,159) (6,205) (6,205)
Net cash provided by operating activities 367,288 274,285 512,210
Investing activities:      
Purchase of property and equipment (137,064) (130,464) (104,824)
Proceeds from disposal of assets 2,003 11,683 1,150
Proceeds from Insurance Settlement, Investing Activities 3,477 5,114 6,322
Payments to Acquire Interest in Joint Venture 0 0 (20,000)
Distribution from joint venture 3,835 3,460 2,500
Net cash used in investing activities (127,749) (110,207) (114,852)
Financing activities:      
Principal payments on long-term debt and capital lease obligations (162,066) (90,483) (3,284)
Cash dividends paid (11,108) (9,424) (9,787)
Purchase of treasury stock (129,884) (223,013) (240,171)
Issuance cost of line of credit 0 (1,115) 0
Net cash used in financing activities (303,058) (324,035) (253,242)
(Decrease) increase in cash and cash equivalents (63,519) (159,957) 144,116
Cash and cash equivalents, beginning of year 187,028 346,985 202,869
Cash and cash equivalents, end of year 123,509 187,028 346,985
Non-cash transactions:      
Accrued capital expenditures 2,597 23,084 3,453
Stock awards 2,688 2,680 2,671
Accrued treasury stock purchases $ 0 $ 2,000 $ 6,002